Inhibrx

Antibody-based immunotherapeutics for cancer and infectious diseases

placeSolana Beach, California, United States calendar_todayFounded 2009 groups112 employees language inhibrx.com

Registered entities

Innovation

49 patent families (16 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 7,815 times.

YearFilings
20155
20164
20178
20189
201910
202024
202125
202221
202330
202425
20254
20262

Social engagement

Social engagement: 7.4K social following, 8 posts in the last 12 months — below the industry typical range.

Investor mix

10 investors on record; lead investors include Viking Global Investors.

Investor typeCountShare
Venture capital110%
Private equity110%
Bank & private debt110%
Other / undisclosed770%

Recent activity

31 May 2026
Event
2026 ASCO Annual Meeting
22 May 2026
Event
2026 ASCO Annual Meeting
11 May 2026
Product launch
INBRX-106
Coming soon